Drupal.behaviors.print = function(context) {window.print();window.close();}>
Siemens Sees Opportunity for NGS in Clinical Dx as it Transitions HIV Assay to MiSeq
November 09, 2011
Siemens Sees Opportunity for NGS in Clinical Dx as it Transitions HIV Assay to MiSeq
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Illumina Plans to Submit MiSeqDx Assays for Cystic Fibrosis to FDA this Year
November 1, 2012 / Clinical Sequencing News
Illumina and Siemens to Co-Develop MDx Tests on the MiSeq
November 2, 2011 / Clinical Sequencing News
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News
Analysts Increase Valuations, Upgrade Illumina
January 4, 2013 / GenomeWeb Daily News